Nimodipine oral solution - Arbor Pharmaceuticals

Drug Profile

Nimodipine oral solution - Arbor Pharmaceuticals

Alternative Names: AR 02; Nymalize

Latest Information Update: 16 Dec 2013

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Arbor Pharmaceuticals
  • Class Antihypertensives; Dihydropyridines
  • Mechanism of Action Calcium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Subarachnoid haemorrhage
  • New Molecular Entity No

Highest Development Phases

  • Marketed Subarachnoid haemorrhage

Most Recent Events

  • 16 Dec 2013 Launched for Subarachnoid haemorrhage in USA (PO) before 16 December 2013 - First global launch
  • 13 May 2013 Registered for Subarachnoid haemorrhage in USA (PO) - First global approval
  • 02 Dec 2011 AR 02 receives Fast Track designation for Undefined in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top